Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Jen Wieczner
Stay informed with Jen Wieczner’s coverage and analysis for Coins2Day.
Page 29 of 51
Finance
Billionaire Investor Steven Cohen Pledges $325 Million to Combat PTSD in Vets
By
Trading Desk
Finance
Meet the Only Female Activist Hedge Fund Manager Shaking up U.S. Companies
By
Investment Desk
Finance
Carl Icahn Is Mulling a Bid For Herbalife
By
Digital Assets Editor
Finance
Here’s Why Alibaba Will Never Buy Back Yahoo Stake
By
Editorial Team
Finance
Hedge Fund Manager Who Spotted Fraud at Enron Calls Tesla ‘The Anti-Amazon’
By
Crypto Correspondent
Finance
Bridgewater’s Ray Dalio Says Fed Doesn’t Need To Raise Interest Rates
By
Market Analyst
MPW
Why the CEO Behind the EpiPen Controversy Remains One of Coins2Day’s Most Powerful Women
By
Research Team
Finance
Here’s How Much Bill Ackman Has Already Made on Chipotle
By
Editorial Team
Finance
5 Things We Just Learned About the Tesla-SolarCity Deal
By
Financial Writer
Finance
The Truth About Mylan CEO’s ‘Heather Bresch Situation’ and Her MBA
By
Staff Writer
Finance
What Mylan’s EpiPen Cost Scandal Says About the Drug Price Problem
By
Research Team
Tech
Why WhatsApp Could Be A Game-Changer for American Health Care
By
Staff Writer
Finance
Mylan CEO Blamed Obamacare for EpiPen Sticker Shock
By
Market Analyst
Finance
Pfizer’s Medivation Deal May Not Be Enough
By
Investment Desk
The Twisted and Deadly Story Behind the Neuromama Stock Scheme
By
Research Team